Seeing Is Believing
Currently out of the existing stock ratings of Richard Newitter, 265 are a BUY (59.02%), 181 are a HOLD (40.31%), 3 are a SELL (0.67%).
Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 67.2% that have a potential upside of 20.75% achieved within 192 days.
Richard Newitter’s has documented 886 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 30-Sep-2025.
Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 4/21/2021. The price target of $286.67 was fulfilled within 1 day with a profit of $10.46 (3.52%) receiving and performance score of 35.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$85
$7.62 (9.85%)
$100
10 days ago
(28-Sep-2025)
4/5 (80%)
$10.89 (14.69%)
119
Hold
$77.53
$0.15 (0.19%)
$85.88
1 months 18 days ago
(20-Aug-2025)
2/2 (100%)
$-1.65 (-2.08%)
111
Buy
$110
$32.62 (42.16%)
$120
1 months 18 days ago
(20-Aug-2025)
8/11 (72.73%)
$30.82 (38.92%)
338
Buy
$95
$17.62 (22.77%)
$108
1 months 18 days ago
(20-Aug-2025)
7/11 (63.64%)
$15.82 (19.98%)
285
Buy
$107
$29.62 (38.28%)
$107
1 months 19 days ago
(19-Aug-2025)
15/27 (55.56%)
$25.96 (32.03%)
396
Which stock is Richard Newitter is most bullish on?
Which stock is Richard Newitter is most reserved on?
What Year was the first public recommendation made by Richard Newitter?